Observation on the Clinical Efficacy of Acupoint Application Therapy of Kechuan Powder for Chronic Bronchial Asthma in the Persistent Phase

Objective:To observe the clinical efficacy of acupoint application therapy by Kechuan Powder on chronic bronchial asthma in the persistent phase.Methods:58 cases were randomly divided into control group and acupoint application of Kechuan Powder group(acupoint application group).The patients in the acupoint application group mainly received acupoint application by Kechuan Powder.The patients in the control group were given Western medicine therapy only.All the treatment lasted for 6 weeks.It was to observe integral change of syndromes in Chinese medicine before and after treatment,scores of ACT,pulmonary ventilation function[peak expiratory flow(PEF),force expiratory volume in the first second(FEV1)],and frequency of acute attack in 1 year after treatment.Results:The total effective rate was 64.28% in control group and was 86.67% in acupoint application group,indicating significant difference in comparison(P0.05).It was discovered that the therapy in acupoint application group improved integral efficacy on syndromes in Chinese medicine and scores of ACT for the patient of chronic bronchial asthma in the persistent phase,reduced the frequency of acute attack in 1 year and increased PEF and FEV1 levels in pulmonary function,which was superior to those in control group(P0.05).Conclusion:Acupoint application therapy by KCP may relieve the clinical symptoms of asthma,diminish the times of asthma attack and improve the control level of asthma.And using acupoint application with KCP can improve the lung function of chronic persistent asthma patients with mild or midrange degree.The therapeutic effect was significant.So Acupoint application therapy by KCP is an effective treatment of bronchial asthma.